![Karl Elmqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Elmqvist
Chief Investment Officer bei
FLERIE INVEST AB
Profil
Karl Elmqvist currently works at Flerie Invest AB, as Investment Manager from 2022, AnaCardio AB, as Board Observer from 2022, and Flerie AB, as Investment Manager from 2022.
Mr. Elmqvist also formerly worked at Imperial Consulting, Inc., as Analyst in 2016, Guy's & St Thomas' Charity, as Foundation Doctor from 2020 to 2021, Tetra Pak Holdings AB, as Internship in 2015, Qvartz AB, as Intern in 2018, and Doctrin AB, as Project Manager from 2019 to 2020.
Mr. Elmqvist received his undergraduate degree in 2018 from Imperial College London and undergraduate degree in 2016 from Imperial College Business School.
Aktive Positionen von Karl Elmqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| FLERIE INVEST AB | Chief Investment Officer | 01.10.2022 |
AnaCardio AB
 AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Direktor/Vorstandsmitglied | 01.09.2022 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Private Equity Investor | 01.10.2022 |
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that engages in development of immunotherapeutic treatments | Direktor/Vorstandsmitglied | 01.10.2023 |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Karl Elmqvist
| Unternehmen | Position | Ende |
|---|---|---|
Guy's & St Thomas' Charity
 Guy's & St Thomas' Charity Services to the Health IndustryHealth Services Provides healthcare services for charity | Direktor/Vorstandsmitglied | 31.08.2021 |
Doctrin AB
 Doctrin AB Internet Software/ServicesTechnology Services Provides digitizes patient history | Corporate Officer/Principal | 31.05.2020 |
Qvartz AB
 Qvartz AB Provides financial advice | Corporate Officer/Principal | 31.05.2018 |
Imperial Consulting, Inc. | Corporate Officer/Principal | 31.03.2016 |
| ░░░░░ ░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Karl Elmqvist
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Imperial Consulting, Inc. | |
Guy's & St Thomas' Charity
Guy's & St Thomas' Charity Services to the Health IndustryHealth Services Provides healthcare services for charity | Health Services |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Finance |
Imperial College Business School
 Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Health Technology |
Tetra Pak Holdings AB | |
Qvartz AB
Qvartz AB Provides financial advice | |
Doctrin AB
Doctrin AB Internet Software/ServicesTechnology Services Provides digitizes patient history | Technology Services |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that engages in development of immunotherapeutic treatments | Commercial Services |
